Current developments in the use of stem cell for therapeutic neovascularisation: is the future therapy "cell-free"?

Yang, Zijiang; Di Santo, Stefano; Kalka, Christoph (2010). Current developments in the use of stem cell for therapeutic neovascularisation: is the future therapy "cell-free"? Swiss medical weekly, 140, w13130. EMH Schweizerischer Ärzteverlag 10.4414/smw.2010.13130

Preview

Text smw-2010-13130.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (484kB) | Preview

The plasticity and self-regenerative properties of stem cells have opened new avenues in regenerative medicine. Greater understanding of the biology of stem cells is followed by growing expectations of a rapid translation into alternative therapeutic options. Recent preclinical studies and clinical trials employing stem and progenitor cells from different sources have shown encouraging results. However, their underlying mechanisms are still poorly understood, the potential adverse effects and the discrepancy in efficacy remain to be further investigated. Their essential role in vessel regeneration has made endothelial progenitor cells (EPC) a suitable candidate for therapeutic applications aiming at tissue revascularisation. Recent evidence suggests that EPC contribute to neovascularisation not only by direct participation in tissue homeostasis but mainly via paracrine mechanisms. In future, novel therapeutic strategies could be based on EPC paracrine factors or synthetic factors, and replace cell transplantation.

Interest & Impact

Downloads

264 since deposited on 13 Jul 2015
15 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item